- AKBA -4.87%
Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations
Yahoo Finance · 1 hour ago
Search results
- 1.2650Add to watchlist-0.0650 (-4.87%)As of Fri. May 10, 2024 10:45 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open1.2500High1.3300Low1.2400
- Mkt Cap265.14MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.330052 Wk. Low0.780052 Wk. High2.4800
Top storiesRelated stocks
Discover real-time Akebia Therapeutics, Inc. Common Stock (AKBA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Akebia Therapeutics Inc. May 08 • 04:00PM ET. 1.40. 0.00 0.00% Healthcare • Biotechnology • USA • NASD. Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert. Draw. Ideas. Candle - advanced. Intraday. Daily. Weekly. Monthly.
Per-Share Earnings, Actuals and Estimates. View the latest Akebia Therapeutics Inc. (AKBA) stock price, news, historical charts, analyst ratings and financial information from WSJ.
According to 3 analysts, the average rating for AKBA stock is "Strong Buy." The 12-month stock price forecast is $4.67, which is an increase of 227.72% from the latest price.
Akebia Therapeutics, Inc. Common Stock (AKBA) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.
Find the latest Akebia Therapeutics, Inc. (AKBA) stock quote, history, news and other vital information to help you with your stock trading and investing.
May 3, 2024 · A high-level overview of Akebia Therapeutics, Inc. (AKBA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
